Risk Profile Improvements

  • Securities Litigation (removed) — Eli Lilly lawsuit over false advertising of TRIM product present in baseline but absent from current filing with no resolution disclosed.
NASDAQ: MGRX MANGOCEUTICALS, INC. 10-K

Mangoceuticals loss doubles to $20.6M; auditor flags going-concern, capital insufficient for 12 months

Filed April 1, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 20, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade MGRX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Feedback
View original filing on SEC.gov View full financials on EDGAR ↗

Generated by AI · Jun 3, 2026 8:26 PM